In previous studies, sulfoxide metabolite was observed in animal and h
uman intestinal perfusions of cimetidine and other H-2-antagonists in
vivo. L-Methionine, imipramine, and the anionic exchange inhibitor dii
sothiocyanostilbene-2,2'-disulfonic acid reduced metabolite appearance
. A sequence of follow-up studies is underway, for the purpose of asse
ssing the contributions of drug metabolism and drug and metabolite tra
nsport to variable drug absorption. In this regard, drug-drug and drug
-nutrient interactions represent a primary focus of this research. The
S-oxidation of cimetidine in mammalian small intestinal microsomes wa
s studied from three different species and two intestinal regions. Bas
ed on preparation activity and tissue availability, the relative contr
ibutions of flavin-containing monooxygenases and cytochrome P450 enzym
es to cimetidine sulfoxidation were evaluated in rabbit jejunal micros
omes. Additional inhibitor studies were carried out to evaluate the ro
le of microsomal cimetidine sulfoxidation in the previous in vivo obse
rvations.